3.65
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 3.65 | 04:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 3.65 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.55 | 3.65 | 0.10 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.65 | USD |
Zynerba Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 106.78M | 29.26M | 25.92M | $ - | $ - | -1.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.66 | 4.46 | 3.40 | 3.78 | 1,210,733 | -0.01 | -0.27% |
| 1 Month | 3.49 | 4.46 | 3.16 | 3.60 | 553,977 | 0.16 | 4.58% |
| 3 Months | 3.80 | 4.46 | 3.16 | 3.75 | 561,199 | -0.15 | -3.95% |
| 6 Months | 3.98 | 7.79 | 2.80 | 4.48 | 1,178,481 | -0.33 | -8.29% |
| 1 Year | 8.47 | 8.83 | 2.55 | 4.75 | 869,468 | -4.82 | -56.91% |
| 3 Years | 9.78 | 16.47 | 2.55 | 7.99 | 861,385 | -6.13 | -62.68% |
| 5 Years | 15.05 | 25.95 | 2.55 | 9.16 | 670,667 | -11.40 | -75.75% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates. |
